Form S-1

Bukit Jalil Global Acquisition 1 Ltd. Announces the Separate Trading of its Ordinary Shares, Warrants, and Rights, Commencing on August 21, 2023

Retrieved on: 
Thursday, August 17, 2023
Transfer, Exercise, Unit, Telephone, Managed file transfer, EDGAR, Sale, Prospectus, Form S-1, Offering, Form, Madison Avenue, Security (finance)

Holders of Units will need to have their brokers contact the Company's transfer agent, Continental Stock Transfer & Trust Company, in order to separate the holders’ Units into ordinary shares, warrants, and rights.

Key Points: 
  • Holders of Units will need to have their brokers contact the Company's transfer agent, Continental Stock Transfer & Trust Company, in order to separate the holders’ Units into ordinary shares, warrants, and rights.
  • The Units were initially offered by the Company in an underwritten offering.
  • A.G.P./Alliance Global Partners acted as the sole book-running manager for the Offering.
  • 333-272605) relating to these securities was declared effective by the Securities and Exchange Commission (the “SEC”) on June 27, 2023.

SRM Entertainment, Inc. Announces Closing of Its Initial Public Offering

Retrieved on: 
Wednesday, August 16, 2023
Benchmark, ATTN:, SRM, Telephone, SEC filing, Sale, Prospectus, Form S-1, Offering, Form, Madison Avenue, EF Hutton, Security (finance)

Jupiter, FL, Aug. 16, 2023 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc. (the “Company”) today announced the closing of its initial public offering (the “Offering”) of 1,250,000 shares of its common stock at an initial price to the public of $5.00 per share.

Key Points: 
  • Jupiter, FL, Aug. 16, 2023 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc. (the “Company”) today announced the closing of its initial public offering (the “Offering”) of 1,250,000 shares of its common stock at an initial price to the public of $5.00 per share.
  • The shares began trading on the Nasdaq Capital Market on August 15, 2023, under the symbol “SRM”.
  • The Company received aggregate gross proceeds of $6.25 million from the offering, before deducting underwriting discounts and commissions and other related expenses payable by the Company.
  • In addition, SRM has granted the underwriters a 45-day option to purchase up to an additional 187,500 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.

180 Life Sciences Corp. Announces Closing of $3 Million Public Offering

Retrieved on: 
Monday, August 14, 2023
Marketing, PALO, Telephone, Free File, Research, Sale, Prospectus, Form S-1, Contracture, Warrant, Form, Madison Avenue, Security (finance)

The warrants are immediately exercisable at an exercise price of $0.65 per share and will expire October 10, 2028.

Key Points: 
  • The warrants are immediately exercisable at an exercise price of $0.65 per share and will expire October 10, 2028.
  • The gross proceeds from the offering are approximately $3 million, before deducting the placement agent’s fees and other offering expenses.
  • A.G.P./Alliance Global Partners acted as the sole placement agent for the offering.
  • A final prospectus relating to the offering was filed with the SEC and is available on the SEC's website at http://www.sec.gov.

Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering

Retrieved on: 
Friday, August 11, 2023
Attention, Telephone, Park Avenue, Free File, Sale, Suite, Yield10 Bioscience, Form S-1, Prospectus, Form, Security (finance)

WOBURN, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the pricing of its public offering of 5,750,000 units at a public offering price of $0.65 per unit.

Key Points: 
  • WOBURN, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the pricing of its public offering of 5,750,000 units at a public offering price of $0.65 per unit.
  • Gross proceeds, before deducting placement agent fees and other offering expenses, are expected to be approximately $3.7 million.
  • The offering is expected to close on or about August 15, 2023, subject to the satisfaction of customary closing conditions.
  • A final prospectus relating to and describing the terms of the public offering will be filed with the SEC.

180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering

Retrieved on: 
Thursday, August 10, 2023
Marketing, PALO, Telephone, Free File, Research, Sale, Prospectus, Form S-1, Contracture, Warrant, Form, Madison Avenue, Security (finance)

The warrants will be immediately exercisable at an exercise price of $0.65 per share and will expire October 10, 2028.

Key Points: 
  • The warrants will be immediately exercisable at an exercise price of $0.65 per share and will expire October 10, 2028.
  • The gross proceeds from the offering are expected to be approximately $3 million, before deducting the placement agent’s fees and other offering expenses.
  • The closing of the offering is expected to occur on or about August 14, 2023, subject to the satisfaction of customary closing conditions.
  • A final prospectus relating to the offering will be filed with the SEC and will be available on the SEC's website at http://www.sec.gov.

Aridis Pharmaceuticals Announces $2 Million Offering

Retrieved on: 
Wednesday, August 2, 2023
Park Avenue, File hosting service, Sale, 3rd Floor, Prospectus, Form S-1, OTC, Form, Security (finance)

The closing of the offering is expected to occur on or about August 4, 2023, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about August 4, 2023, subject to the satisfaction of customary closing conditions.
  • The gross proceeds to the Company from the offering are expected to be $2 million, before deducting the placement agent’s fees and other offering expenses payable by the Company.
  • Aridis Pharmaceuticals currently intends to use the net proceeds from the offering for working capital and general corporate purposes.
  • The offering is being made only by means of a prospectus, which is part of the effective registration statement.

First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering

Retrieved on: 
Wednesday, July 19, 2023
Form, Sale, Security (finance), Prospectus, Form S-1, BOCA, Enterprise file synchronization and sharing, Roth Capital Partners

The closing of the offering is expected to occur on or about July 21, 2023, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about July 21, 2023, subject to the satisfaction of customary closing conditions.
  • The gross proceeds to the Company from the offering are expected to be approximately $2.1 million, before deducting the placement agent’s fees and other offering expenses payable by the Company.
  • The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.
  • The public offering is being made only by means of a prospectus, which is part of the effective registration statement.

ARYA Sciences Acquisition Corp V will redeem its Class A Ordinary Shares and will not consummate an initial business combination

Retrieved on: 
Monday, July 3, 2023
Commission, Tax, Trust, Article, Bangladesh Securities and Exchange Commission, Accounting, Wind, Register, Form S-1, Acquisition, Interest on Lawyer Trust Accounts, Form, Finance Secretary (India), Articles of association, Security (finance)

The Company will not hold a general meeting in view of amending its Articles and seeking an extension of the time period it has to consummate a business combination.

Key Points: 
  • The Company will not hold a general meeting in view of amending its Articles and seeking an extension of the time period it has to consummate a business combination.
  • The per-share redemption price for the Public Shares will be approximately $10.37 (the “Redemption Amount”).
  • The Company’s sponsor has agreed to waive its redemption rights with respect to its outstanding Class B ordinary shares issued prior to the Company’s initial public offering.
  • After July 15, 2023, the Company shall cease all operations except for those required to wind up the Company’s business.

Alliance Entertainment Announces Pricing of Public Offering and Nasdaq Listing

Retrieved on: 
Thursday, June 29, 2023
Technology, Electronic Games, Entertainment, Specialty, General Entertainment, Film & Motion Pictures, Music, Retail, Consumer Electronics, Online Retail, Electronics, ThinkEquity, Free File, Alliance Films, Securities and Exchange Commission (Nigeria), Video, Prospectus, Form S-1, State Street, Form, Security (finance)

Alliance Entertainment Holding Corporation (Nasdaq: AENT) (“Alliance Entertainment”, “Company”), a distributor and wholesaler of the world’s largest in stock selection of music, movies, video games, electronics, arcades, and collectibles, today announced the pricing of a public offering of 1,335,000 shares of Alliance Entertainment’s Class A common stock at a price to the public of $3.00 per share for aggregate gross proceeds of approximately $4.0 million, prior to deducting underwriting discounts and offering expenses.

Key Points: 
  • Alliance Entertainment Holding Corporation (Nasdaq: AENT) (“Alliance Entertainment”, “Company”), a distributor and wholesaler of the world’s largest in stock selection of music, movies, video games, electronics, arcades, and collectibles, today announced the pricing of a public offering of 1,335,000 shares of Alliance Entertainment’s Class A common stock at a price to the public of $3.00 per share for aggregate gross proceeds of approximately $4.0 million, prior to deducting underwriting discounts and offering expenses.
  • The Company has granted the underwriter a 45-day option to purchase up to 200,250 additional shares of Class A common stock to cover over-allotments at the public offering price, less the underwriting discount.
  • The Company expects to use the net proceeds from this offering for working capital and general corporate purposes.
  • Alliance Entertainment also announced that, concurrent with this offering, its Class A common stock and warrants have been approved for listing on the Nasdaq Capital Market.

Mobiquity Technologies, Inc. Announces Pricing of $3.0 Million Public Offering

Retrieved on: 
Thursday, June 29, 2023
LLP, Advertising, Managed file transfer, Sale, Prospectus, Form S-1, Form, Security (finance), Manatt, Phelps & Phillips

The closing of the offering is expected to occur on or about June 30, 2023, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about June 30, 2023, subject to the satisfaction of customary closing conditions.
  • The Company intends to allocate up to $1,437,500 of the net proceeds to pay off the secured debt and use the remaining proceeds for working capital.
  • Spartan Capital Securities, LLC is acting as placement agent for the offering.
  • The offering is being made only by means of a prospectus forming part of the effective registration statement.